Haemonetics Corporation
HAE
$56.66
-$1.80-3.08%
NYSE
| 12/27/2025 | 09/27/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.56% | 1.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.56% | 1.84% | |||
| Cost of Revenue | 2.95% | 2.45% | |||
| Gross Profit | 3.98% | 1.43% | |||
| SG&A Expenses | 5.80% | 0.15% | |||
| Depreciation & Amortization | -2.23% | -1.84% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.57% | 0.80% | |||
| Operating Income | 3.51% | 5.95% | |||
| Income Before Tax | 16.94% | 13.54% | |||
| Income Tax Expenses | 20.90% | 13.14% | |||
| Earnings from Continuing Operations | 15.66% | 13.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.66% | 13.67% | |||
| EBIT | 3.51% | 5.95% | |||
| EBITDA | 1.59% | 3.58% | |||
| EPS Basic | 17.62% | 14.93% | |||
| Normalized Basic EPS | 5.34% | 10.73% | |||
| EPS Diluted | 17.28% | 15.71% | |||
| Normalized Diluted EPS | 5.08% | 11.10% | |||
| Average Basic Shares Outstanding | -1.68% | -1.08% | |||
| Average Diluted Shares Outstanding | -1.42% | -1.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||